Literature DB >> 3038830

Myocarditis and cardiomyopathy in the dog and cat.

S K Liu.   

Abstract

Myocarditis and cardiomyopathy were diagnosed in 36 dogs from 11 litters, and myoendocarditis and restrictive cardiomyopathy were diagnosed in 51 cats. Most of the dogs and cats died unexpectedly. Spontaneous parvoviral infection in the dogs caused acute (myocytolysis with presence of intranuclear inclusion bodies in the myocytes), subacute (inflammatory reaction and myocytolysis), and chronic (fibrosis and myocytolysis) myocarditis, which led to extensive myocardial fibrosis and abnormality of the myocytes, similar to dilated cardiomyopathy in man. Spontaneous acute, subacute, and chronic myoendocarditis in the cats led to granulation, extensive fibrosis, and necrosis of the myoendocardium, i.e., like restrictive cardiomyopathy which occurs in man without eosinophilia. Thus, the dog and cat are important animal models of primary myocardial disease.

Entities:  

Mesh:

Year:  1985        PMID: 3038830     DOI: 10.1007/BF02072377

Source DB:  PubMed          Journal:  Heart Vessels Suppl        ISSN: 0935-736X


  3 in total

1.  A case of juvenile form of dilated cardiomyopathy in a 6-month-old Shiba Inu dog.

Authors:  Koichi Shimizu; Ryohei Suzuki; Yoshitaka Ikeda; Yohei Mochizuki; Takahiro Teshima; Masaki Michishita; Hirotaka Matsumoto; Hidekazu Koyama
Journal:  Can Vet J       Date:  2022-02       Impact factor: 1.008

2.  Molecular screening by polymerase chain reaction detects panleukopenia virus DNA in formalin-fixed hearts from cats with idiopathic cardiomyopathy and myocarditis.

Authors:  K M Meurs; P R Fox; A L Magnon; S Liu; J A Towbin
Journal:  Cardiovasc Pathol       Date:  2000 Mar-Apr       Impact factor: 2.185

3.  Epidemiological and clinical features of the endomyocardial form of restrictive cardiomyopathy in cats: a review of 41 cases.

Authors:  Yusuke Kimura; Ryuji Fukushima; Atsushi Hirakawa; Masayuki Kobayashi; Noboru Machida
Journal:  J Vet Med Sci       Date:  2016-01-28       Impact factor: 1.267

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.